HF
CPRX

HRT Financial’s Catalyst Pharmaceutical CPRX Stock Holding History

HRT Financial’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-108,012
Closed -$2.62M – 2759
2025
Q1 		$2.62M Buy
+108,012
New +$2.43M 0.02% 692
2024
Q4 		– Sell
-105,743
Closed -$2.1M – 2537
2024
Q3 		$2.1M Buy
+105,743
New +$1.96M 0.01% 867
2024
Q1 		– Sell
-37,623
Closed -$632K – 2431
2023
Q4 		$632K Sell
37,623
-20,003
-35% -$273K ﹤0.01% 1242
2023
Q3 		$673K Buy
57,626
+41,747
+263% +$558K 0.01% 1232
2023
Q2 		$213K Sell
15,879
-206,299
-93% -$2.97M ﹤0.01% 1812
2023
Q1 		$3.68M Buy
222,178
+188,073
+551% +$3.1M 0.04% 344
2022
Q4 		$634K Buy
34,105
+888
+3% +$13.7K 0.01% 1260
2022
Q3 		$426K Sell
33,217
-154,902
-82% -$1.84M ﹤0.01% 1755
2022
Q2 		$1.32M Buy
+188,119
New +$1.38M 0.01% 763
2022
Q1 		– Sell
-132,366
Closed -$896K – 3220
2021
Q4 		$896K Buy
132,366
+98,986
+297% +$651K 0.01% 1231
2021
Q3 		$176K Buy
+33,380
New +$183K ﹤0.01% 2737
2021
Q1 		– Sell
-108,714
Closed -$363K – 2748
2020
Q4 		$363K Buy
+108,714
New +$365K 0.01% 1189
2020
Q3 		– Sell
-49,888
Closed -$230K – 1957
2020
Q2 		$230K Buy
+49,888
New +$224K 0.01% 1095

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's CPRX Position: Q2 2025 in Review

HRT Financial sold out of Catalyst Pharmaceutical (CPRX) in Q2 2025, closing a stake of 108,012 shares — an estimated $2.62M sold.

HRT Financial first reported a position in CPRX in Q2 2020 and held it in 13 quarters. The position peaked at $3.68M in Q1 2023. 365 funds tracked by Wall St. Rank hold CPRX as of Q2 2025.

  • HRT Financial reported no remaining Catalyst Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 108,012 Catalyst Pharmaceutical shares in Q2 2025, an estimated $2.62M.
  • HRT Financial first reported a position in Catalyst Pharmaceutical in Q2 2020 and held it in 13 quarters.
  • HRT Financial's Catalyst Pharmaceutical position peaked at $3.68M in Q1 2023.
  • 365 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.